World Antiviral Drugs Market to Exhibit Highest Growth Rates in APAC, Predicts Grand View Research in Its Report Available at MarketPublishers.com06 Apr 2017 • by Natalie Aster
LONDON – The incidence of viral infections increases by over 1 million cases each year with nearly 357 million patients already suffering from one of the four sexually transmitted infections (STIs), like acquired immunodeficiency syndrome (AIDS). The launch of novel efficient antiviral drugs with benefits like increased sensitivity, rapid action and lower adverse effects is forecast to perform as a significant driver of the world’s antiviral drugs market in the coming years.
The worldwide antiviral drugs market is predicted to climb to USD 69.2 billion by the year 2025.
The acceptance of antiviral drugs across the developing countries is likely to be rather high in the coming years; it is attributed to low hygiene levels, enhancing awareness due to favourable government campaigns and escalating number of geriatric population.
The generic drugs sector is poised to register a 7% CAGR during 2017-2025, the robust growth is likely to be fueled majorly by patent expiry of blockbuster drugs used for HIV and HCV treatment.
North America was a top player in the global antiviral drugs market as of 2015, due to enhancing drug development initiatives along with established R&D infrastructure. The APAC regional market is expected to register the fastest growth through 2025.
Gilead Sciences, GlaxoSmithKline, F. Hoffmann-La Roche AG, Bristol-Myers-Squibb, Johnson & Johnson, AbbVie and Merck & Co. are amid the leading players in the market.
A detailed analysis of the antiviral drugs market at various geographical scales is available in the cutting-edge study by Grand View Research, titled “Antiviral Drugs Market Analysis By Mechanism of Action, By Application, And Segment Forecasts, 2014 - 2025”.
This publication contains reliable data on the market segmentation, dynamics, major influencing factors, challenges and opportunities, prevailing development trends, competitive scenario, top players and the hottest issues. Moreover, the report presents a future outlook through 2025.
Follow to the Grand View Research page, where many other research studies by this publisher are available.